|
The American Lung Association Asthma Clinical Research Centers
  |
||||||||||||
|
||||||||||||
 |
||||||||||||
|
||||||||||||
 |
||||||||||||
|
||||||||||||
<!–
The Safety of Inactivated Influenza Vaccine in Adults and Children with Asthma
–><!– The American Lung Association Asthma Clinical Research Centers* –>ABSTRACTBackground Influenza causes substantial morbidity in adults and children with asthma, and vaccination can prevent influenza and its complications. However, there is concern that vaccination may cause exacerbations of asthma.
Methods To investigate the safety of the inactivated trivalent split-virus influenza vaccine in adults and children with asthma, we conducted a multicenter, randomized, double-blind, placebo-controlled, crossover trial in 2032 patients with asthma (age range, 3 to 64 years). The order of injection of vaccine and placebo was assigned randomly, with a mean of 22 days between the injections. Each day during the two weeks after each injection, the patients recorded peak expiratory flow rates, symptoms thought to be related to the injection, use of asthma medications, unscheduled health care visits for asthma, and asthma-related absences from school or work. The primary outcome measure was an exacerbation of asthma in the two weeks after the injections.
Results The frequency of exacerbations of asthma was similar in the two weeks after the influenza vaccination and after placebo injection (28.8 percent and 27.7 percent, respectively; absolute difference, 1.1 percent; 95 percent confidence interval, –1.4 percent to 3.6 percent). The exacerbation rates were similar in subgroups defined according to age, severity of asthma, and other factors. Among symptoms thought to be associated with the injection, only body aches were more frequent after the vaccine injection than after placebo injection (25.1 percent vs. 20.8 percent, P<0.001).
Conclusions The inactivated influenza vaccine is safe to administer to adults and children with asthma, including those with severe asthma. Given the morbidity of influenza, all those with asthma should receive the vaccine annually.
Supported by
CLINICAL PEDIATRIC ONLINE
Yudhasmara Foundation Indonesia
JL Taman Bendungan Asahan 5 Jakarta Indonesia 102010
phone : 62(021) 70081995 – 5703646
email : judarwanto@gmail.com,
http://clinicalpediatric.wordpress.com/
Copyright © 2009, Clinical Pediatric Online Information Education Network. All rights reserved.
Filed under: 01.DISEASE-CONDITION, 07.JOURNAL WATCH
